Global Influenza (Flu) Vaccine Market: Trends & Opportunities (2014-19)
The report titled ‘Global Influenza Vaccine Market: Trends & Opportunities (2014-2019)’ begins with a brief description of the global vaccine market and its two segments - human and veterinary vaccine. It also discusses the global influenza market size for the past five years. Further, the report provides a detailed insight into the global market of influenza vaccine business and covers the various factors influencing the market. It offers market forecast for the next five years. In addition, it also studies the seasonal influenza vaccine market in the United States, Germany, Japan and the United Kingdom. The report concludes with a brief focus on the various trends associated with the global influenza vaccine market and profiling of major key players in the market like Sanofi, Novartis, Abbott Laboratories, CSL and Glaxo Smith Kline.
Glaxo Smith Kline
With the advancement in technology and discovery of new products in the field of medical sciences, vaccines have gained the unquestioned crucial position in the pharmaceutical industry. Vaccines are considered as the most effective health intervention ever developed, saving innumerable lives. The vaccine market is growing at a steady pace, mainly because of the various existing and emerging diseases which can only be prevented with the help of vaccines. Scientists are continuously engaged in the research and development of effective vaccines to eradicate all major life threatening diseases. There are various organizations which supply vaccines at subsidize rate or even free of cost to some of the countries, namely the Global Alliance for Vaccines and Immunizations (GAVI), World Health Organization (WHO), the World Bank, the United Nations Children's Fund (UNICEF) and Bill and Melinda Gates foundation
Influenza vaccine constitutes a significant sector of the overall vaccine market. The public attention associated with Influenza A (H1N1, swine flu) pandemic of 2009, and the growing health awareness in emerging countries has played a detrimental role in defining the dynamics of global influenza market.